Vlado Perkovic

[5] He is also an Honorary Fellow at the George Institute for Global Health Australia[6][circular reference], and a kidney disease researcher leading a number of international clinical trials.

In 2017 Perkovic was appointed to lead the non-communicable diseases theme as part of the University of New South Wales Medicine's thematic research strategy.

Perkovic is a fellow of the Royal Australasian College of Physicians (1999), the American Society of Nephrology, (2008) and the Australian Academy of Health and Medical Sciences (2016).

Some of his previous positions include being President of the Association of Australian Medical Research Institutes (AAMRI, the peak body for Medical Research Institutes), Chairman of the International Society of Nephrology Advancing Clinical Trials initiative (ISN-ACT 2016-), a member of the Executive Committee and Board of Australian Clinical Trials Alliance, (2016-8), a member of the Executive Operations Secretariat, Australasian Kidney Trials Network (2016-) and Chair of the AKTN Scientific Committee 2013-6.

Perkovic's ongoing work includes further systematic reviews, large scale global trials of steroids for the prevention of kidney failure in IgA nephropathy (Co-Principal Investigator), and Steering Committee roles in a number of global, pharma-funded trials studying treatments for the prevention of kidney failure in diabetic nephropathy.